Babagan ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
IndustriBiotechnology
Kantor pusatSeattle, WA
Ngadeg2005
Bentuk hukumC Corporation
StatusAktif
Ulasan
Durung ana ulasan. Wis kerja karo ALLOZYNE INC? Dadi sing pisanan mbage pengalaman.
Angka utama
Mlebu kanggo ndeleng angka-angka utama
Pendapatan, bathi resik, lan jumlah karyawan ALLOZYNE INC saben taun, kanthi sumbere.
Mlebu Gawe akun nganggo email sampeyanGratis
Kanthi nerusake, sampeyan setuju karo Perjanjian Pangguna, Kabijakan Privasi, lan Kabijakan Cookie Heelky.
Informasi hukum
| Jeneng hukum | ALLOZYNE INC |
|---|---|
| Bentuk hukum | C Corporation |
| SEC CIK | 1345630Deleng ing SEC EDGAR ↗ |
| Alamat kadhaftar | Seattle, WA |
| Status | Aktif |
Sumber: SEC EDGAR · dianyari Nov. 14, 2026
Kontak & tautan
Lokasi
Seattle, WA
Apa iki perusahaan sampeyan?
Klaim kaca iki gratis kanggo nambah logo, produk, foto, lan kerja, lan kanggo mangsuli ulasan.
Klaim kaca ikiGabung Heelky kanggo nyambung, nyewa, lan tuwuh
Gawe akun gratis kanggo ngirim pesen, nglamar kerja, lan ngirim misi.
Gabung saiki — gratis